Generation of novel oncolytic vaccinia virus with improved intravenous efficacy through protection against complement-mediated lysis and evasion of neutralization by vaccinia virus-specific antibodies
- J. Immunother. Cancer, 2023 Jan;11(1):e006024 | doi: 10.1136/jitc-2022-006024